Thursday, July 26, 2018

Hope and skepticism abound around Biogen and Eisai Alzheimer’s trial

An antibody called BAN2401 cleared amyloid-β proteins and slowed cognitive decline in people with mild Alzheimer’s disease

via Chemical & Engineering News: Biological SCENE https://ift.tt/2uShLaH

No comments:

Post a Comment